This report highlights the shifting drug policy landscape in Asia, with a special focus on (1) the violent crackdown on drug users and sellers in the Philippines, (2) Thailand's move toward an alternative approach of reducing criminal sanctions for drug use and improving access to medication treatment and needle exchange, and (3) China's emergence as a major source of many new chemical precursors and drugs that are exported outside Asia.
